Clustering ICU patients with sepsis based on the patterns of their circulating biomarkers: A secondary analysis of the CAPTAIN prospective multicenter cohort study

Archive ouverte

Misset, Benoît | Philippart, François | Fitting, Catherine | Bedos, Jean-Pierre | Diehl, Jean-Luc | Hamzaoui, Olfa | Annane, Djillali | Journois, Didier | Parlato, Marianna | Moucadel, Virginie | Cavaillon, Jean-Marc | Coste, Joël

Edité par CCSD ; Public Library of Science -

International audience. Background Although sepsis is a life-threatening condition, its heterogeneous presentation likely explains the negative results of most trials on adjunctive therapy. This study in patients with sepsis aimed to identify subgroups with similar immune profiles and their clinical and outcome correlates. Methods A secondary analysis used data of a prospective multicenter cohort that included patients with early assessment of sepsis. They were described using Predisposition, Insult, Response, Organ failure sepsis (PIRO) staging system. Thirty-eight circulating biomarkers (27 proteins, 11 mRNAs) were assessed at sepsis diagnosis, and their patterns were determined through principal component analysis (PCA). Hierarchical clustering was used to group the patients and k -means algorithm was applied to assess the internal validity of the clusters. Results Two hundred and three patients were assessed, of median age 64.5 [52.0–77.0] years and SAPS2 score 55 [49–61] points. Five main patterns of biomarkers and six clusters of patients (including 42%, 21%, 17%, 9%, 5% and 5% of the patients) were evidenced. Clusters were distinguished according to the certainty of the causal infection, inflammation, use of organ support, pro- and anti-inflammatory activity, and adaptive profile markers. Conclusions In this cohort of patients with suspected sepsis, we individualized clusters which may be described with criteria used to stage sepsis. As these clusters are based on the patterns of circulating biomarkers, whether they might help to predict treatment responsiveness should be addressed in further studies. Trial registration The CAPTAIN study was registered on clinicaltrials.gov on June 22, 2011, # NCT01378169 .

Suggestions

Du même auteur

Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study

Archive ouverte | Parlato, Marianna | CCSD

International audience. PurposeSepsis and non-septic systemic inflammatory response syndrome (SIRS) are the same syndromes, differing by their cause, sepsis being secondary to microbial infection. Microbiological te...

Biomarker cruises in sepsis: who is the CAPTAIN? Discussion on "Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study"

Archive ouverte | Briassoulis, George | CCSD

International audience

Toll-like receptors expression and interferon-γ production by NK cells in human sepsis.

Archive ouverte | Souza-Fonseca-Guimaraes, Fernando | CCSD

International audience. ABSTRACT: INTRODUCTION: During the course of infection, natural killer (NK) cells contribute to innate immunity by producing cytokines, particularly interferon-gamma (IFN-γ). In addition to t...

Chargement des enrichissements...